EIF4E2 anticorps (N-Term)
Aperçu rapide pour EIF4E2 anticorps (N-Term) (ABIN2258705)
Antigène
Voir toutes EIF4E2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- EIF4E2, NT (Eukaryotic Translation Initiation Factor 4E Type 2, eIF4E Type 2, eIF-4E Type 2, mRNA Cap-binding Protein Type 3, Eukaryotic Translation Initiation Factor 4E-like 3, Eukaryotic Translation Initiation Factor 4E Homologous Protein, mRNA Cap-binding Protein 4EHP, eIF4E-like Protein 4E-LP, EIF4EL3)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- Synthetic peptide selected from the N-terminal region of human EIF4E2 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- EIF4E2 (Eukaryotic Translation Initiation Factor 4E Family Member 2 (EIF4E2))
-
Autre désignation
- EIF4E2
-
NCBI Accession
- NP_004837
-
UniProt
- O60573
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-